These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23418957)

  • 1. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
    Golubnitschaja O; Yeghiazaryan K; Costigliola V; Trog D; Braun M; Debald M; Kuhn W; Schild HH
    EPMA J; 2013 Feb; 4(1):6. PubMed ID: 23418957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention.
    Debald M; Yeghiazaryan K; Cebioglu M; Kuhn W; Schild HH; Golubnitschaja O
    EPMA J; 2013 Sep; 4(1):22. PubMed ID: 24228816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.
    Golubnitschaja O; Debald M; Yeghiazaryan K; Kuhn W; Pešta M; Costigliola V; Grech G
    Tumour Biol; 2016 Oct; 37(10):12941-12957. PubMed ID: 27448308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within 'Horizon 2020'.
    Lemke HU; Golubnitschaja O
    EPMA J; 2014; 5(1):8. PubMed ID: 24883142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper.
    Golubnitschaja O; Kinkorova J; Costigliola V
    EPMA J; 2014 Apr; 5(1):6. PubMed ID: 24708704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.
    Polivka J; Altun I; Golubnitschaja O
    EPMA J; 2018 Mar; 9(1):1-13. PubMed ID: 29515683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?
    Polivka J; Kralickova M; Polivka J; Kaiser C; Kuhn W; Golubnitschaja O
    EPMA J; 2017 Jun; 8(2):119-127. PubMed ID: 28824737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine.
    Golubnitschaja O; Filep N; Yeghiazaryan K; Blom HJ; Hofmann-Apitius M; Kuhn W
    Amino Acids; 2018 Apr; 50(3-4):383-395. PubMed ID: 29249020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine.
    Golubnitschaja O; Costigliola V;
    EPMA J; 2012 Nov; 3(1):14. PubMed ID: 23116135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal breast cancer: European challenge and innovative concepts.
    Smokovski I; Risteski M; Polivka J; Zubor P; Konieczka K; Costigliola V; Golubnitschaja O
    EPMA J; 2017 Jun; 8(2):159-169. PubMed ID: 28824739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.
    Mazurakova A; Koklesova L; Vybohova D; Samec M; Kudela E; Biringer K; Šudomová M; Hassan STS; Kello M; Büsselberg D; Golubnitschaja O; Kubatka P
    Front Pharmacol; 2023; 14():1160068. PubMed ID: 37089930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human-at-work systems in business sustainability: perspectives based on expert and qualified production workers in a manufacturing enterprise.
    Genaidy AM; Rinder MM; Sequeira R; A-Rehim A
    Ergonomics; 2010 Apr; 53(4):559-85. PubMed ID: 20309751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
    Morigi C
    Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.